Internal Medicine, Infectious Disease · Voorhees, NJ
NPI
1851603120
Since 2010
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
709 Haddonfield Berlin Rd, Garden State Infectious Diseases Associates, P.A.
Voorhees, NJ, 08043
Phone (856) 566-3190
Groups this clinician bills Medicare through
Medicare paid, 2024
$105K
1,122 services
Medicare patients, 2024
450
Average age 73
Drug cost, 2024
$3.5M
3,835 prescriptions
Company payments, 2025
$102
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Condoluci was code 99233 (hospital e&m - subsequent), 586 times for 253 patients. In total Mark Condoluci billed 1,122 services in 19 codes, and Medicare paid $105K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 586 | 253 | $95.91 | $56K |
| 99222 Hospital E&M - Initial | Facility | 275 | 241 | $102.05 | $28K |
| 99214 Office E&M - Established | Office | 73 | 39 | $71.22 | $5,199 |
| 99232 Hospital E&M - Subsequent | Facility | 59 | 49 | $64.06 | $3,779 |
| 99223 Hospital E&M - Initial | Facility | 38 | 38 | $141.26 | $5,368 |
| 99213 Office E&M - Established | Office | 32 | 25 | $51.54 | $1,649 |
| 99221 Hospital E&M - Initial | Facility | 19 | 19 | $64.24 | $1,221 |
By year: 2022 $132K for 1,445 services; 2023 $116K for 1,212 services; 2024 $105K for 1,122 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark Condoluci prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 318 prescriptions and refills. In total Mark Condoluci wrote 3,835 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 318 | 346 | 34 | $1.3M |
| Atorvastatin Calcium Generic | 135 | 213 | 19 | $547 |
| Valacyclovir Valacyclovir Hcl | 121 | 157 | 19 | $4,568 |
| Tamsulosin Hcl Generic | 113 | 140 | 14 | $614 |
| Amlodipine Besylate Generic | 105 | 133 | 13 | $148 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 89 | 99 | Under 11 | $370K |
| Ritonavir Generic | 77 | 130 | 12 | $11K |
| Descovy Emtricitabine/Tenofov Alafenam | 77 | 77 | Under 11 | $168K |
| Gabapentin Generic | 72 | 92 | Under 11 | $576 |
| Tivicay Dolutegravir Sodium | 71 | 71 | Under 11 | $157K |
| Fenofibrate Fenofibrate Nanocrystallized | 69 | 88 | Under 11 | $591 |
| Metoprolol Succinate Generic | 67 | 113 | Under 11 | $460 |
| Juluca Dolutegravir/Rilpivirine | 67 | 85 | Under 11 | $293K |
| Hydrochlorothiazide Generic | 63 | 94 | Under 11 | $160 |
| Rosuvastatin Calcium Generic | 58 | 94 | Under 11 | $464 |
Brand drugs: - claims; generic drugs: 2,767 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Condoluci $102 ($102 in general payments such as food, travel and fees) from 2 companies. The largest payer was Insmed, Inc. with $77.87.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 4 | $77.87 |
| THD America, Inc. | 1 | $23.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.